Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Anti-Hypertensive Drugs - Benelux

Benelux
  • In Benelux, the projected revenue in the Anti-Hypertensive Drugs market is estimated to reach US$233.70m in 2024.
  • By 2029, the market volume is expected to reach US$228.90m, showing an annual growth rate (CAGR 2024-2029) of -0.41%.
  • However, it is important to note that in a global comparison, United States is anticipated to generate the highest revenue in the Anti-Hypertensive Drugs market.
  • In 2024, United States is projected to generate US$12.29bn in revenue.
  • In Benelux, the demand for generic anti-hypertensive drugs is on the rise due to the increasing cost of branded medications.

Definition:
Anti-hypertensive drugs are used to treat high blood pressure. This market covers different types of anti-hypertensive drugs, such as calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), beta blockers, and thiazide diuretics.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Johnson & Johnson, AstraZeneca, Boehringer Ingelheim

In-Scope

  • Drugs to treat high blood pressure
  • Pulmonary hypertension

Out-Of-Scope

  • Anti-coagulants
  • Anti-fibrinolytics
  • Cardiology devices
  • Blood pressure meters
Anti-Hypertensive Drugs: market data & analysis - Cover

Market Insights report

Anti-Hypertensive Drugs: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Anti-Hypertensive Drugs market in Benelux is a dynamic and evolving market that has experienced significant growth in recent years.

    Customer preferences:
    The customers in the Anti-Hypertensive Drugs market in Benelux are increasingly demanding more personalized and effective treatments for hypertension. They are also becoming more aware of the side effects of traditional drugs and are seeking alternative treatments. As a result, there is a growing demand for innovative and safer drugs that can provide better outcomes for patients.

    Trends in the market:
    One of the key trends in the Anti-Hypertensive Drugs market in Benelux is the increasing adoption of combination therapies. Combination therapies are becoming more popular as they offer a more effective treatment option for patients who do not respond well to traditional monotherapies. Another trend in the market is the growing demand for generic drugs. This is driven by the need to reduce healthcare costs and the expiration of patents for some of the leading anti-hypertensive drugs.

    Local special circumstances:
    The Anti-Hypertensive Drugs market in Benelux is characterized by a high level of competition among drug manufacturers. This is due to the presence of several established players in the market, as well as the entry of new players. The market is also heavily regulated, with strict rules and regulations governing the approval and marketing of drugs.

    Underlying macroeconomic factors:
    The Anti-Hypertensive Drugs market in Benelux is influenced by several macroeconomic factors, including the aging population, increasing prevalence of hypertension, and rising healthcare costs. The aging population is driving the demand for anti-hypertensive drugs, as hypertension is more common in older adults. The increasing prevalence of hypertension is also contributing to the growth of the market. Additionally, rising healthcare costs are driving the need for more cost-effective treatments, such as generic drugs.In conclusion, the Anti-Hypertensive Drugs market in Benelux is a competitive and evolving market that is driven by the need for more personalized and effective treatments for hypertension. The market is characterized by the growing adoption of combination therapies and the demand for generic drugs. The market is heavily regulated, and there are several macroeconomic factors that are influencing its growth, including the aging population, increasing prevalence of hypertension, and rising healthcare costs.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Anti-Hypertensive Drugs: market data & analysis - BackgroundAnti-Hypertensive Drugs: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.